These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Rao CV, Hirose Y, Indranie C, Reddy BS. Cancer Res; 2001 Mar 01; 61(5):1927-33. PubMed ID: 11280748 [Abstract] [Full Text] [Related]
3. Early events in human colorectal carcinogenesis. Aberrant crypts and microadenoma. Roncucci L. Ital J Gastroenterol; 1992 Mar 01; 24(9):498-501. PubMed ID: 1489980 [Abstract] [Full Text] [Related]
5. Transforming growth factor alpha distribution in rectal crypts as a biomarker of decreased colon cancer risk in patients consuming cellulose. Hardman WE, Cameron IL, Beer WH, Speeg KV, Kadakia SC, Lang KA. Cancer Epidemiol Biomarkers Prev; 1997 Aug 01; 6(8):633-7. PubMed ID: 9264277 [Abstract] [Full Text] [Related]
6. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia. Hurlstone DP, Karajeh M, Sanders DS, Drew SK, Cross SS. Am J Gastroenterol; 2005 Jun 01; 100(6):1283-9. PubMed ID: 15929758 [Abstract] [Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1996 Aug 01; 383():1-370. PubMed ID: 12692653 [Abstract] [Full Text] [Related]
8. Aberrant crypt foci and beta-catenin accumulated crypts; significance and roles for colorectal carcinogenesis. Mori H, Yamada Y, Kuno T, Hirose Y. Mutat Res; 2004 May 01; 566(3):191-208. PubMed ID: 15082237 [Abstract] [Full Text] [Related]
9. Intervention trials on colorectal cancer prevention. Faivre J, Couillault C, Belghiti C. IARC Sci Publ; 1996 May 01; (139):115-24. PubMed ID: 8923023 [Abstract] [Full Text] [Related]
10. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells. Raju J, Patlolla JM, Swamy MV, Rao CV. Cancer Epidemiol Biomarkers Prev; 2004 Aug 01; 13(8):1392-8. PubMed ID: 15298963 [Abstract] [Full Text] [Related]
11. Aberrant crypt foci in colon cancer epidemiology. Khare S, Chaudhary K, Bissonnette M, Carroll R. Methods Mol Biol; 2009 Aug 01; 472():373-86. PubMed ID: 19107443 [Abstract] [Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of Polybrominated Biphenyls (CAS No. 67774-32-7)(Firemaster FF-1(R)) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1993 Aug 01; 398():1-235. PubMed ID: 12637961 [Abstract] [Full Text] [Related]
13. Chemoprevention of colorectal cancer. Niitsu Y, Takayama T, Miyanishi K, Nobuoka A, Hayashi T, Kukitsu T, Takanashi K, Ishiwatari H, Abe T, Kogawa T, Takahashi M, Matsunaga T, Kato J. Cancer Chemother Pharmacol; 2004 Sep 01; 54 Suppl 1():S40-3. PubMed ID: 15309513 [Abstract] [Full Text] [Related]
14. A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies. Bernstein C, Bernstein H, Garewal H, Dinning P, Jabi R, Sampliner RE, McCuskey MK, Panda M, Roe DJ, L'Heureux L, Payne C. Cancer Res; 1999 May 15; 59(10):2353-7. PubMed ID: 10344743 [Abstract] [Full Text] [Related]
15. Chemoprevention of large bowel carcinogenesis; the role of control of cell proliferation and significance of beta-catenin-accumulated crypts as a new biomarker. Mori H, Yamada Y, Hirose Y, Kuno T, Katayama M, Sakata K, Yoshida K, Sugie S, Hara A, Yoshimi N. Eur J Cancer Prev; 2002 Aug 15; 11 Suppl 2():S71-5. PubMed ID: 12570338 [Abstract] [Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program . Natl Toxicol Program Tech Rep Ser; 1994 Feb 15; 430():1-280. PubMed ID: 12616301 [Abstract] [Full Text] [Related]